Ester Baiget never planned to be CEO. Then a future bioscience giant came calling (2026-06-23)
Novonesis CEO Ester Baiget reflects on the decision to leave Dow after 25 years to lead Novozymes, and why impact, not ambition, drove the move. She discusses the family values that shaped her, redefining the company as a biosolutions leader, the Chr. Hansen merger and why leadership requires courage, respect and long-term purpose.